Sectors

Data Insights

Caficrestat by Applied Therapeutics for Cardiomyopathy: Likelihood of Approval

Data Insights

Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval

Data Insights

OMT-28 by OMEICOS Therapeutics for Mitochondrial Myopathy: Likelihood of Approval

Data Insights

LIOCYXM-004 by Lion TCR for Hepatocellular Carcinoma: Likelihood of Approval

Data Insights

EVX-02 by Evaxion Biotech for Melanoma: Likelihood of Approval

Data Insights

SBT-101 by SwanBio Therapeutics for Adrenomyeloneuropathy (AMN): Likelihood of Approval

Data Insights

TDM-105795 by Technoderma Medicines for Androgenic Alopecia: Likelihood of Approval

Data Insights

(Chlorthalidone + losartan) by Laboratorios Silanes for Idiopathic (Essential) Hypertension: Likelihood of Approval

Clinical Trials

News

GRO Biosciences secures Series B funding for gout treatment

News

US CDC recommends routine RSV vaccination for older adults

News

Oncoinvent’s Radspherin has FDA fast-track status for ovarian cancer

Drug Manufacturers

Partner Content

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Interviews

Drug development costs predicted to soar as BIOSECURE Act gains momentum

Phalguni Deswal

Partner Content

Join the revolution of on-dose authentication

Therapy Area

News

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

News

Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy

Phalguni Deswal

News

ConSynance wins FDA designation for Prader-Willi syndrome therapy

Pricing and Market Access

Analyst Comment

The US Biosecure Act threatens to destabilise the pharmaceutical industry

Analyst Comment

UK’s antibiotic subscription funding model – a route to market sustainability?

Analyst Comment

Ukraine: a market access review over two years of war

Sign up to the newsletter: In Brief

Your corporate email address *

First name *

Last name *

Company name *

Job title *

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close